EuroMedtech™ 2011 to make Turin the medtech funding hotspot
Over 20 leading medtech investor firms seek new innovations at EuroMedtech 2011
Zurich, Switzerland and Turin, Italy – April 12, 2011: Now in its third year, EBD Group's partnering event for the medical technology industry, EuroMedtech™, has become the premier destination for emerging innovator companies and start-ups to seek out and secure funding. For these companies, EuroMedtech provides a unique opportunity to meet with and present to many potential strategic partners and qualified investors over a two-day period.
To be held at the Torino Incontra Conference Center in Turin, Italy on May 16–17, EuroMedtech 2011 is expected to attract over 20 leading venture capital firms, including 360° Capital Partners, BioMedPartners, Citigroup, DFJ Esprit, Edmond de Rothschild Investment Partners, Entrepreneurs Fund, Gilde Healthcare Partners, High-Tech Gruenderfonds Management, IJ Partners, Merieux Development, MVM Life Science Partners, NBGI Ventures, SEED Capital Denmark, Seventure Partners, SGECR, SHAM, Sofimac Partners Capital Investissement, TBG Management, Tech Coast Angels, Vaekstfonden, and Ysios Capital Partners.
Based on the successful business outcomes generated at last year’s event, the stage is set for EuroMedtech 2011 to accelerate the business and partnering objectives of participating companies. One of the most common objectives for both public and private companies is funding.
As James Wong of NBGI Ventures explained, "Emerging companies developing breakthrough products are a vital source of innovation for the growing medical technology industry. As specialist venture capital investors, for the past decade NBGI Ventures has supported European and US companies developing disruptive medical technologies. We have continued our participation at EuroMedtech since its inception as it is one of the leading European conferences that provides a focused and exclusive platform for medical technology start-ups, multinationals, investors and advisors to interact and explore potential collaborations."
The unique features of EuroMedtech were further emphasized by Martin Pfister from High-Tech Gruenderfonds. "The High-Tech Gruenderfonds, leading seed investor in Germany, sees EuroMedtech as a great opportunity to pick up the newest trends in medtech. We encourage our portfolio companies to present and participate in the partnering because the conference is unique in bringing together the European industry, service companies and investors with a focus on medtech."
Powered by partneringONE®, the industry's most advanced partnering system, EuroMedtech facilitates one-to-one meetings between emerging innovator firms, large multidisciplinary healthcare and biomedical companies, investment firms and service providers. Companies interesting in applying to present can do so online at www.ebdgroup.com/emt.
About EBD Group
EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group's partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.
EBD Group's conferences are run with the support of leading corporations and international trade associations and include:
- BIO-Europe® and BIO-Europe Spring®, Europe's largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
- BioPharm America™, the fastest growing partnering event in North America
- Biotech Showcase™, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors
- BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
- ChinaBio® Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio® LLC
- EuroMedtech™, EBD Group's partnering event for the innovative medical technology industry
- The Global Impact Forum™, a unique and innovative partnering conference in impact investing and venture philanthropy.
EBD Group's sophisticated web-based partnering service, partneringONE®, is used as the partnering engine at numerous third-party events around the world, and partnering360® is the open online community of life science dealmakers that enhances partnering experiences throughout the year.
EBD Group is an Informa company. Informa is the largest publicly-owned organizer of exhibitions, conferences and training in the world.
EBD Group has offices in the USA and Europe.
For more information please visit www.ebdgroup.com.Contact:
1 760 930 0500
About the Health Technology Cluster
The Health Technology Cluster (HC) is an inter-sectoral network for increasing innovative capacity and international competitiveness of Health Technology companies, their suppliers as well as relevant research and healthcare facilities. The HC currently connect 220 partner companies from Austria and South Germany. Due to the Upper Austrian strength in medical technology, the main focus is on medical electronics, software, clean room & hygiene, hospital equipment, end-user products, diagnostics-pharma and materials (metal/plastics). More detailed information under www.gesundheitstechnologie-cluster.at.
Stephanie Rieß, M.A.
Communication Health Technology Cluster (Clusterland Oberösterreich GmbH)
+43 732 79810 5158
Please find the digital version under www.gesundheitstechnologie-cluster.at/presse